397 related articles for article (PubMed ID: 34552597)
1. TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease.
Jones EL; Laidlaw SM; Dustin LB
Front Immunol; 2021; 12():738473. PubMed ID: 34552597
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
Chan EKL
Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
[TBL] [Abstract][Full Text] [Related]
3. The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review.
Oke V; Wahren-Herlenius M
J Autoimmun; 2012 Aug; 39(1-2):77-82. PubMed ID: 22402340
[TBL] [Abstract][Full Text] [Related]
4. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases.
Lee AYS; Reed JH; Gordon TP
J Autoimmun; 2021 Nov; 124():102724. PubMed ID: 34464814
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
7. Ro52/TRIM21 - From host defense to autoimmunity.
Holwek E; Opinc-Rosiak A; Sarnik J; Makowska J
Cell Immunol; 2023; 393-394():104776. PubMed ID: 37857191
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
Espinosa A; Hennig J; Ambrosi A; Anandapadmanaban M; Abelius MS; Sheng Y; Nyberg F; Arrowsmith CH; Sunnerhagen M; Wahren-Herlenius M
J Biol Chem; 2011 Oct; 286(42):36478-91. PubMed ID: 21862588
[TBL] [Abstract][Full Text] [Related]
9. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity.
Lee AYS
Rheumatol Int; 2017 Aug; 37(8):1323-1333. PubMed ID: 28417151
[TBL] [Abstract][Full Text] [Related]
10. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.
Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjöstrand M; Eloranta ML; Ní Gabhann J; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
J Exp Med; 2009 Aug; 206(8):1661-71. PubMed ID: 19635858
[TBL] [Abstract][Full Text] [Related]
11. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
12. Anti-Ro52/TRIM21 antibodies are associated with aberrant inflammatory circuits in patients with systemic autoimmune rheumatic diseases.
Amezcua-Guerra LM; Pérez-García LF; Jiménez-Rojas V; Márquez-Velasco R; Silveira LH
Gac Med Mex; 2023; 159(1):55-64. PubMed ID: 36930561
[TBL] [Abstract][Full Text] [Related]
13. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
[TBL] [Abstract][Full Text] [Related]
14. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
[TBL] [Abstract][Full Text] [Related]
15. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
[TBL] [Abstract][Full Text] [Related]
16. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
17. Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
Infantino M; Meacci F; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Ott A; Meyer W; Atzeni F; Sarzi-Puttini P; Manfredi M; Bizzaro N
Arthritis Res Ther; 2015 Dec; 17():365. PubMed ID: 26673754
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
[TBL] [Abstract][Full Text] [Related]
19. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response.
Routsias JG; Tzioufas AG
J Autoimmun; 2010 Nov; 35(3):256-64. PubMed ID: 20643529
[TBL] [Abstract][Full Text] [Related]
20. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Kvarnström M; Brokstad KA; Jonsson R; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2014 Jul; 177(1):244-52. PubMed ID: 24673429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
